Beth Israel Deaconess (Harvard) — Boston, Massachusetts

Beth Israel Deaconess (Harvard) is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 46/100 (POOR). This profile has not yet been claimed by the site owner.

Beth Israel Deaconess (Harvard) has participated in 1 clinical trials.

Therapeutic areas: Regional Citrate Anticoagulation (RCA), Continuous Renal Replacement Therapy (CRRT), Acute Kidney Injury.

Sponsors: Vantive Health LLC.

Sponsor Feasibility Report

Trust Score: 46/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Beth Israel Deaconess (Harvard)?

Beth Israel Deaconess (Harvard) has a Crixeo Trust Score of 46/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Beth Israel Deaconess (Harvard) conducted?

Beth Israel Deaconess (Harvard) has 1 clinical trials on record. Their work covers Regional Citrate Anticoagulation (RCA), Continuous Renal Replacement Therapy (CRRT), Acute Kidney Injury.

Is Beth Israel Deaconess (Harvard) accredited by Crixeo Health?

Beth Israel Deaconess (Harvard) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Beth Israel Deaconess (Harvard)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.